Dr. Julia Carrier has been a pivotal member of Eliquent since 2016, bringing over 20 years of distinguished expertise in drug discovery and preclinical development. As a pharmacologist and toxicologist, she specializes in the nonclinical development of chemical compounds, biologics, cell and gene therapies, and drug-device combination products. At Eliquent, Dr. Carrier leads a team of accomplished PhD professionals, offering a comprehensive array of consulting services that encompass everything from drafting development strategies to preparing for regulatory meetings and filing materials. She has successfully led multiple FDA meetings and discussions, focusing on creating streamlined yet comprehensive nonclinical programs tailored to support the lifecycle of drugs and biologics.

Fluent in both English and Mandarin, Dr. Carrier has effectively managed complex teams and projects in multicultural and global settings. Her extensive knowledge of drug discovery, combined with hands-on experience in preclinical studies, enables her to routinely conduct thorough safety assessments, review protocols and study reports, and author or evaluate nonclinical development plans that meet the rigorous regulations of the US, EU, and China. Her work spans a diverse range of therapeutic indications, including oncology, autoimmunity, infectious diseases, and pain management, utilizing various modalities such as CGTs/ATMPs, mRNA and protein therapies, vaccines, blood products, small molecules, and liver biotherapeutics. Furthermore, she has collaborated closely with sponsors to source and manage pharmacology, ADME, and GLP safety studies at contract research organizations (CROs).

Before joining Eliquent, Dr. Carrier honed her skills at Pfizer, where she led and supported preclinical developments of immune-regulatory drugs. Her work there emphasized the intricacies of adaptive and innate immunity, focusing on novel cytokine/chemokine pathways and biomarker identification. An accomplished scientist, she has authored high-quality publications in the realms of autoimmunity, inflammation, and neurodegenerative diseases, including prestigious publications in Nature.

Dr. Carrier holds a B.S. in Medicinal Chemistry from Peking University, a Ph.D. in Immunology and Molecular Pathogenesis from Emory University and completed her postdoctoral studies at Harvard University. She is an American Board-Certified Toxicologist and a certified Project Management Professional (PMP).